Author:
Roy Sushmita,Schmuck Eric G.,Raval Amish N.
Publisher
Springer Nature Singapore
Reference147 articles.
1. Adamiak M, Cheng G, Bobis-Wozowicz S, Zhao L, Kedracka-Krok S, Samanta A, Karnas E et al (2018) Induced Pluripotent Stem Cell (iPSC)-derived extracellular vesicles are safer and more effective for cardiac repair than iPSCs. Circ Res 122:296–309
2. Adams WJ, Zhang Y, Cloutier J, Kuchimanchi P, Newton G, Sehrawat S, Aird WC et al (2013) Functional vascular endothelium derived from human induced pluripotent stem cells. Stem Cell Rep 1:105–113
3. Ahmed RPH, Haider KH, Buccini S, Shujia J, Ashraf M (2011) Reprogramming of skeletal myoblasts for induction of pluripotency for tumor free cardiomyogenesis in the infarcted hear. Circ Res 109:60–70
4. Al-Khani AM, Khalifa MA, Haider KH (2022) Mesenchymal stem cells: how close we are to their routine clinical use? In: Haider KH (ed) Handbook of stem cell therapy. Springer, Singapore. https://doi.org/10.1007/978-981-16-6016-0_11-1
5. Al-Omar MT, Alnajjar MT, Ahmed ZT, Salaas FMI, Alrefaei TSM, Haider KH (2022) Endothelial progenitor cell-derived small extracellular vesicles for myocardial angiogenesis and revascularization. J Clin Transl Res 8:476–487